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1. Introduction
The surgeon is generally regarded by the intelligentsia 
of science and medicine as a mechanical craftsman if not 
“hewer of wood and drawer of water”. Surgery has always 
been a practical art, the treatment of disease by manual 
processes, and the education of a surgeon, as that of any 
craftsman, has been by apprenticeship through the ages. 
But as noted by Hunter – the founder of the scientifi c basis 
of surgery – a surgeon is more than an operator, does more 
than repetitive work and adds something of his own to the 
store of knowledge he received. And adding something to 
knowledge can scarcely happen except through enquiry into 
problems he may have encountered at the bed-side.
I should dearly love to say that I wished to become a 
surgeon when I was a school boy and that I had enjoyed 
dissecting dead frogs and looking after sick animals. But 
I grew up with no such ambition and no clear goal. My 
family tradition in medicine had been strong for over two 
generations and a grand uncle who studied medicine in 
Edinburgh in 1902 had long been our hero. It was therefore 
natural that I grew up on an unstated assumption that I 
would follow the family tradition. The die was cast in 1951 
when I joined the fi rst batch for MBBS in the Trivandrum 
Medical College. Medical education is so overregulated 
and overburdened with examinations that medical colleges 
in India lack the intellectual climate for research except 
when a great teacher kindles the spirit of enquiry. I was 
fortunate to have one in Professor Thangavelu who taught 
us pathology. While taking a class on infl ammation, he once 
questioned us on the reaction of pus. Some of us voted for 
acidic, others for alkaline, and the non-aligned preferred 
neutral. He listened patiently and said “I know you will go 
to the library this evening and look up text books to fi nd the 
answer to my question. Let me tell you there is a better way 
to fi nd the answer. You take litmus paper with you when you 
go to the wards tomorrow and check the reaction of pus in 
several patients; also look at the diagnosis and reports of 
bacterial culture. You would then know that the reaction 
can vary and the cause too can vary”. Listening to him, the 
scales fell from my eyes, and I saw at once that the pursuit 
of knowledge would not be possible without the use of one’s 
mind and experiment; what was gained in the absence of 
one or both was an illusion of knowledge. I never forgot that 
lesson.
2. Liver function studies
My introduction to scientifi c enquiry was incidental to 
my surgical training. As a medical student in Trivandrum 
and surgical trainee in Liverpool, UK, I had observed the 
devastating consequences of cirrhosis of the liver which is 
a common malady. The patients in Trivandrum approached 
the hospital when their scarred liver had blocked the entry of 
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venous blood and raised the portal venous pressure so high that 
they bled profusely from venous “varices” in the esophagus; 
alternately, they would come when the scarring had blocked 
the exit of blood from the liver, with massive exudation of 
fl uid in the abdomen called ascites. While bleeding ended 
life quickly, ascites drained it away by degrees. Both assured 
certain destruction. When I had to choose a topic for fulfi lling 
the research component of the Ch.M degree of the Liverpool 
University in 1960, I sought the advice of Professor A K 
Basu of Kolkata who was a reputed authority in the newly 
emerging fi eld of portal hypertension. He promptly suggested 
the role of secondary hyperaldosteronism in the perpetuation 
of cirrhotic ascites for my study. On the recommendation 
of Professor Wells, my teacher in the University, I was 
awarded a Fellowship in the Department of Dr John Gibbon 
of the Jefferson Medical College, Philadelphia to carry out 
my research and my immediate supervisor was Dr Walter 
Ballinger who was a strong proponent of surgical research. In 
reviewing the literature, I soon found that the removal of the 
adrenal glands had been done in intractable ascites in some 
two dozen patients on the expectation that adrenalectomy 
would rid the patient of hyper aldosteronism and relieve him 
of ascites. However the patients continued to have ascites 
after the operation even though the accumulation of fl uid in 
the abdomen had decreased. In other words, the tendency to 
retain sodium and water in the abdomen had been curtailed, 
but not eliminated, by the removal of the adrenal glands. 
What else could be responsible for the perpetuation of 
ascites? Arguably, the liver itself could have a role because 
it was known that obstruction to the exit of portal venous 
blood from the liver was immediately followed by ascites in 
certain clinical syndromes and in the experimental model. 
It was therefore logical that liver would be part of an array 
of body mechanisms to retain salt, an array which evolved 
as life moved from the sea to land and the conservation 
of salt in the body became essential for survival. The role 
of the liver could have become dormant as more potent 
mechanisms such as the one involving aldosterone emerged 
but its atavistic role could reassert itself if and when the 
newer mechanisms disappeared. I tested this hypothesis in 
a canine model of experimental ascites and wrote my thesis 
for Ch.M on the basis of the study, which was also published 
(Lalonde et al 1964). My hepatic obsession continued when 
I returned to India and joined the faculty of the Postgraduate 
Institute of Medical Education and Research, Chandigarh 
which was in its infancy in those far off days. Professor 
Aikat who headed the Department of Pathology had 
observed with Iber and others earlier in Kolkata that portal 
hypertension could develop in the absence of cirrhosis and 
with apparently normal liver-function tests in a condition 
called “non-cirhotic portal fi brosis”. It did not take long for 
us to spot this syndrome in Chandigarh and hold discussions 
on its causation, pathogenesis and management. When I 
raised the possibility that the normal values in biochemical 
tests could have more to do with the large reserve capacity 
of the liver than with the status of liver function, and that an 
electrophysiologic test of the liver might give more accurate 
information on liver dysfunction, Professor Aikat was 
amused. Given my limited knowledge of electrophysiology, 
I imagined that the electrical activity of hepatic cells in the 
fantastically active organ would summate and produce a 
measurable electro-hepatogram. I found no support for this 
idea among my colleagues including a biophysicist who 
did not welcome a surgeon’s intrusion on his turf. As I was 
an admirer of J B S Haldane, who respected no intellectual 
boundaries and was a physiologist at one stage, I sought his 
response on the possible existence of an electro-hepatogram. 
Haldane who was seriously ill replied a few months later 
(fi gure 1).
However by mid 1964 my interest in liver disease and 
general surgery as a whole was yielding place to the pull of 
cardiac surgery which was making dramatic progress and 
giving new life to children and those with valvular heart 
disease. The seed had been sewn during my tenure at the 
Jefferson Medical College where Gibbon had made history 
by developing a heart-lung machine during two decades 
of innovative experimental work. He had demonstrated 
for the fi rst time in 1953 that the machine could be used 
successfully in a clinical open heart operation to close an 
atrial septal defect. The saga of Gibbon’s endeavour had 
made as profound an impression on me as had his unfailing 
consideration and encouragement to surgical residents and 
Fellows like myself. It was therefore with much excitement 
that I welcomed the opportunity to join the Department of 
Cardiac Surgery at the Johns Hopkins Hospital as a Fellow of 
Dr Vincent Gott prior to my move to the George Washington 
University for clinical training in cardiothoracic surgery. 
Though my laboratory schedule was heavy, Dr Gott gave me 
time and facilities to pursue my old interest in the electro-
hepatogram as a collateral activity at the Hopkins. The study 
showed that the canine biliary tract was electrically positive 
with reference to the liver capsule, and potentials ranged 
between 3 to 15 mv. Intraportal infusion of dextrose and 
insulin caused a brief fall in potential followed by a sharp 
increase (Valiathan et al 1967). These results vindicated 
Haldane’s belief that measurable electrical activity in the 
liver “would be associated with biliary secretion rather than 
more important metabolic activities”. That paper marked my 
farewell to studies on the liver.
3. At Johns Hopkins
3.1 Blood compatible materials
The next chapter as a Fellow at the Johns Hopkins 
University with Dr Gott as my mentor was a turning point 
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in so far as it infl uenced my approach to cardiac surgery and 
the course of my life itself. Warm hearted and gentle, Gott 
was generous to a fault and too self-effacing to mention 
his brilliant background in the University of Minnesota 
as a trainee under Dr Lillehei. He was a key player in the 
path-breaking advances – there were many – which took 
place in Dr Lillehei’s outstanding programme which nurtured 
a generation of world leaders in cardiac surgery. He came to 
Hopkins with a formidable reputation from the University of 
Wisconsin where he had made the serendipitous observation 
that heparin would bind to rigid materials and make their 
surface blood compatible provided they had been treated 
earlier with colloidal graphite and benzalkonium chloride 
sequentially (Gott et al 1963). His observation became a 
trail blazer because no fewer that 20–25 surfaces with the 
wall-bonding of heparin and other molecules emerged in 
the following two decades. It seemed to offer new hopes 
for replacing damaged heart valves and diseased arteries, 
the demand for which had become insistent following the 
advent of open heart surgery. However the new materials 
sought had to possess far greater and more durable blood 
compatibility than what siliconised materials had provided 
till then. In an attempt to reduce clot formation on artifi cial 
heart valves, Gott had evaluated a number of materials in the 
highly thrombogenic environment of the canine vena cava. 
Not surprisingly the rings made of different materials were 
partly or fully fi lled with clots in a few hours: the surprise 
was the fact that rings of methyl methacrylate coated with 
graphite stayed open for as long as 14 days. This was 
initially attributed to the physical properties of colloidal 
graphite such as smoothness and negative zeta potential but 
subsequent studies revealed that the graphite-benzalkonium-
heparin (GBH) surface owed its thrombo resistance to the 
ability to bind heparin following exposure to a cationic 
Figure 1. Haldane’s letter.
surface active agent, benzal konium chloride. Thanks to the 
adsorptive property, graphite bound the cationic detergent 
which has surface active properties, and the positively 
charged ammonium radical on the cationic detergent in turn, 
bound heparin which is a polysaccharide containing three 
negatively charged sulphate groups per unit. In spite of the 
bond being ionic, heparin was suffi ciently stable to withstand 
the systemic challenge of protamine which is routinely used 
for neutralizing heparin in open heart surgery (Whiffen et al 
1964). I was deeply involved in the experimental evaluation 
of the GBH surface by the implantation of leafl ets and rings, 
which confi rmed its thrombo-resistance. In an expanded 
study where specially fabricated rings of polymeric materials, 
stainless steel, silicone and GBH coated polycarbonate were 
implanted in the inferior vena cava, the uncoated rings 
clotted in two hours whereas the coated rings stayed open 
for two weeks (Gott et al 1968). The junction between a 
prosthetic valve and the inner layer of the heart was a special 
focus of our investigations as thrombosis seemed to begin at 
that interface (Valiathan et al 1966). The junction between 
the endocardium and a prosthetic material or between bone 
and a ceramic – between, in fact, the living and non-living, 
continues to remain vulnerable in all implants. A molecular 
union between the living tissue and a prosthetic material 
would revolutionise the history of bio-implants. It remains 
the Grail of tissue engineers. 
While the thrombo-resistant property of GBH was no 
longer in doubt, we were aware of its drawbacks such as 
the durability of the heparin-bonding being limited to hours 
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Figure 2. Dr Vincent Gott at Johns Hopkins, 2008.
Figure 3. Aneurysm of the thoracic aorta, view from the left chest after resection; the black, GBH coated shunt (arrow) can be seen.
 
rather than days; poor tolerance of the semi-rigid GBH-coated 
surface to repeated bending or the application of surgical 
clamps. These drawbacks did not stop its application in an 
experimental double-chambered artifi cial heart designed 
by our group (Topaz et al 1967) and a simplifi ed technique 
for resecting thoracic aortic aneurysms. These aneurysms 
grow progressively and result in fatal rupture unless they 
are resected early and reconstructed with a vascular graft. 
But resection posed serious dangers due to the temporary 
interruption of blood fl ow through the aorta, which was 
required to carry out the surgical procedure. The dangers 
included the sharp elevation of blood pressure above the 
level of interruption and deprivation of blood supply to the 
spinal cord and kidney below the interruption. To prevent 
these complications, the technique in the early sixties 
employed a temporary left heart bypass, complete with the 
suspension of coagulation in the patient by heparin injection, 
insertion of a temporary shunt between the left atrium and 
femoral artery, and the use of an external pump. This was 
a cumbersome and diffi cult procedure as the deliberate 
suspension of coagulation caused troublesome bleeding. We 
recognised that a temporary shunt from the aorta above the 
level of the aneurysm to a downstream location would do the 
job just as well provided the shunt would remain thrombo-
resistant during the two or three hours of the procedure for 
resection and grafting. GBH met the requirements admirably 
and, after much experimental work, a GBH-coated shunt was 
used successfully for resecting aneurysms of the thoracic 
aorta at the Hopkins (Valiathan et al 1968, fi gure 3).
A non-graphited, heparinised version of the bypass system 
known as “Gott shunt” was commercialised in later years. 
My Fellowship under Gott at the Hopkins was one of the 
happiest and most productive periods in my life as a surgeon 
and investigator (Valiathan 1969). There is something in the 
air at Hopkins, which never fails to recharge one’s mind. 
4. At the Georgetown University Hospital: from 
materials to devices
My Fellowship in thoracic surgery at the George Washington 
University Hospital, Washington DC under Dr Brian Blades 
who had done the fi rst dissection lobectomy of the lung in 
the nineteen thirties was followed by training in cardiac 
surgery under Dr Charles Hufnagel at the Georgetown 
University Hospital in the same city (see fi gure 4).
Hufnagel was a legendary fi gure. In 1947 he had 
used highly polished methyl methacrylate tubes for the 
permanent intubation of the thoracic aorta in dogs and 
developed an ingenious “multiple point fi xation” to fi x the 
tube to the aorta in 2–3 min without stitches or continuous 
circumferential pressure on the aortic wall. By 1950, he had 
developed a workable ball valve prosthesis. The cage of the 
valve in which the ball moved up and down was constructed 
of highly polished methyl methacrylate and the ball was 
hollow and made of plexiglass. After 100 experiments 
in dogs, he was suffi ciently confi dent and encouraged to 
place the valve in a patient ill with aortic regurgitation in 
September 1952 before the advent of heart-lung bypass. It 
was a landmark event and by 1954 twenty three patients in 
advanced condition had been treated with results far superior 
to those of medical treatment. Apart from his surgical skill 
and innovative mind, Hufnagel was a supreme individualist 
who insisted on using a ventricular pump, micro-crimped 
vascular graft, disc oxygenator and so on which were 
designed by him and made according to his specifi cations! 
He was a hard task master who never suffered fools gladly. 
When I joined his service in 1967, he was still at the peak 
of his powers and had developed a new “unitized, trileafl et 
valve” for replacing the diseased aortic valve. My years with 
Hufnagel as a Fellow and later, as an Instructor initiated 
me into cardiac surgery and gave me an inside view of the 
engineering of cardiovascular devices. The background at 
Hopkins with blood compatible materials was an invaluable 
asset which enabled me to take to the development of a 
prosthetic heart valve and other complex devices at the 
Georgetown University as a duck takes to water. I resembled 
an actor rehearsing a role in full vigour without the faintest 
idea where my play would be staged.
5. A stop at Indian Institute of Technology, Chennai
On returning to India against Hufnagel’s warning – “The 
Indian virus will destroy you” -, I had an uncertain start. I 
began my migrant career at the Safdarjung Hospital, Delhi 
which taught me the ground realities of thoracic surgery in 
India and how to deal with tough problems such as children 
in severe distress from acute staphylococcal empyema and 
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Figure 4. Dr Charles Hufnagel with the author during a visit to 
the Chitra Institute, 1985.
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a Hb level of 7 g/100 ml, which had never confronted me 
abroad. There was no possibility of doing cardiac surgery 
or doing research at Safdarjung, which would have been 
inappropriate in any case when emergency services in 
thoracic surgery were inadequate. My next stop was Indian 
Institute of Technology (IIT), Chennai where Dr Arcot 
Ramachandran offered me a Visiting Professorship with 
permission to operate in the Railway Hospital, Perambur 
thrice a week. My assignments in IIT included teaching 
a course in physiology, contributing to seminars and 
interacting with MS students whose projects covered nearly 
everything in medical sciences. I was however disappointed 
that R&D received low priority in the IIT scheme of 
technical education; a student could spend three years on 
modelling the aortic valve without getting any closer to 
making a prototype. As the students were bright and keen, 
there was no reason why each well conceived project could 
not have led to a product. Needless to say, my heart valve 
concept made no progress during my IIT interlude.
6. Chitra Institute, Thiruvananthapuram: 
TTK Chitra valve
As in the affairs of men, there is a tide in the life of ideas, and 
the upswing of the valve project coincided with my move 
to the Sree Chitra Institute, Thiruvananthapuram in 1974. 
“Institute” was a misnomer because it had a building with 
incomplete facilities, no furniture or equipment, and a staff of 
exactly fi ve consisting of security and secretarial personnel! 
However, I knew instinctively that the stage was set and I had 
to perform a role for which I had rehearsed in faraway US. 
Side by side with the commissioning of a speciality hospital, 
I submitted a project for the development of titanium and 
polyvinyl chloride (PVC) for medical applications with 
Ramaseshan of the National Aerospace Laboratory (NAL), 
Bangalore and Gowarikar of Vikram Sarabhai Space Centre 
(VSSC), Thiruvananthapuream as collaborators. The project 
was aimed at developing titanium for implants including a 
heart valve and PVC for a variety of disposables such as 
blood bag and oxygenator. Following the approval of the 
project by the Science and Engineering Council (SERC), 
I brought two biomedical engineers as Research Fellows 
to the Chitra Institute, including Bhuvaneshwar who was a 
bright student of mine at the IIT and is currently the Head of 
the Biomedical Technology Wing of the Chitra Institute.
The development of a valvular prosthesis which had 
been a technological challenge acquired moral overtones 
when the Chitra hospital opened its doors to patients. The 
Indian Council of Medical Research (ICMR), New Delhi 
had reported in a working paper that 6 out of 1000 children 
between 5 – 15 years in India were susceptible to rheumatic 
fever, which put the young population at risk to valvular 
heart disease at over a million. While prophylaxis at the 
level of the community was the ultimate answer to this 
huge problem, we were fl ooded with patients who urgently 
needed valve replacement, but were too poor to pay for the 
valve. Nothing was more painful or more cruel than the 
denial of a surgical procedure to a patient on the ground that 
a life saving device was beyond his or her means. The failure 
to reach out to the suffering on the ground of economics was 
a violation of the basic goal of medicine “for the good of 
many, for the wellbeing of many”. Soon we put together a 
small group with Bhuvaneshwar as the principal investigator 
to develop a prosthetic valve of tilting disc design which 
would fully conform to the ISO 5840 standards. The team 
included Neelakantan Nair who organized a Tool Room 
which could fabricate the metallic components of the 
valve; and Arthur Vjayan Lal, a veterinary surgeon, who 
put together the animal care facility and operating room 
where heart valve replacement could be done in sheep with 
predictable survival. Ramani who joined later as the Head of 
the Biomedical Technology Wing was an excellent engineer 
who provided constant support through creative monitoring 
and trouble shooting. Ramaseshan kept a benign watch over 
the R&D efforts and came to our rescue in times of crisis 
with innovative suggestions. 
The TTK-Chitra valve which is currently marketed, has 
been implanted in over 26,000 patients and is said to claim 
over a third of the Indian valve market (fi gure 5a). It costs a 
third of the price of imported valves of similar design and 
has penetrated markets in developing countries such as South 
Africa and Bangladesh. The company has recently built an 
expanded manufacturing facility which should comply with 
European norms leading to “CE” certifi cation and produce up 
to 10,000 units a year. This successful valve (model 4) stands 
on the foundations of three earlier models which failed and 
caused our group no little disappointment. Therein lies a tale 
of setbacks, struggle and the resolve not to quit.
A prosthetic valve has three parts, a metallic housing; a 
disc or ball which functions as an occluder; and a sewing 
ring of plastic fabric (table 1).
In model 1, the major and minor struts were electron-
beam welded and the valve was expected to withstand 360 
million cycles of disc movement in the accelerated wear 
tester, which would correspond to what a natural valve does 
in the heart during a 10 year period. To our dismay, the major 
strut fractured at the weld after a mere 100,000 cycles (fi gure 
5b). Thanks to Dr Valluri, the fracture was studied in the 
NAL; it turned out that weld embrittlement was the cause of 
fracture. It was clear that titanium welded components were 
inherently unsafe in the high-fatigue, high-stress location 
of a heart valve, and the housing had to be integrally 
machined to eliminate this structural weakness. Additionally 
the polyacetal disc in the model absorbed 0.5% moisture 
with a small dimensional change, which was reversible 
but disturbing. In model 2, the disc was made of single 
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crystal sapphire which was inert and blood compatible. 
The new all-integral cage required the development of new 
fabrication process, in which the housing was carved out of 
a block of titanium. This was achieved by the innovative use 
of conventional and copy-milling techniques. This model 
failed because of the extensive wear of titanium struts and 
the escape of the disc. We were intrigued that the wear did 
not occur in the accelerated wear tester and came to light 
only in the animal model. We discovered the hard way that 
glycerol in the wear test chamber had acted as an excellent 
lubricant and prevented the wear! Model 3 had a housing 
made of a high wear-resistance aerospace superalloy, called 
“Haynes-25” (a cobalt based alloy with chromium, nickel 
and tungsten) – harder to machine than titanium – which 
was coated with titanium nitride to match the hardness of 
the sapphire disc. The integral-cage was machined from 
rods of this very diffi cult-to-machine alloy using CNC 
wire-cut and electric-discharge machining (EDM). This 
model went through all the tests successfully and several 
sheep were alive and well for months with the valve in their 
mitral position. In fact, we decided to seek the approval of 
the Institutional Ethics Committee (IEC) for its clinical trial 
in late 1986, when disaster struck and one animal which 
had valve replacement three months earlier dropped dead 
suddenly. Necropsy showed that the sapphire disc had 
fractured (fi gure 5c). We were faced with a major crisis after 
a decade of toil, when critics including the media did not 
spare us or our effort. Our group held urgent discussions 
in consultation with Ramaseshan and decided to give up 
not only sapphire but rigid discs altogether. Mashelkar of 
National Chemcial Laboratory (NCL), Pune suggested fi ve 
new plastic candidates which we screened through improved 
techniques for wear resistance before choosing ultra high 
molecular weight polyethylene (UHMW-PE) for making 
the occluder of the current model (model 4). Fabrication of 
the disc from UHMW-PE was no easy task because we were 
demanding no less than a marriage of the unbreakability 
of rubber with the polish of a mirror in the new disc! The 
blanks had to be cut from the plastic rods under cryogenic 
conditions, disc machined, and thermal polishing done in 
a stainless steel die with controlled heating and cooling 
cycles even as a uniform compressive load was applied. The 
fl ash generated during this process had to be removed with 
a polished tool under cryogenic conditions again. It took 
eighteen months to standardize this process cycle and attain 
the required quality fi nish and dimensional control of the 
disc in model 4, which was largely accomplished by a young 
engineer Muraleedharan who had joined Bhuvaneshwar. In 
design features, hydrodynamic tests, accelerated durability 
tests and trials in sheep, model 4 performed extremely well 
and compared favourably with the Bjork-Shiley standard 
disc valve which was used internationally at that time. The 
choice of a soft disc gave model 4 the additional advantages 
of low impact forces, less potential for cavitation and low 
closing sounds. Bhuvaneshwar and team showed remarkable 
skill in designing and fabricating a pulse duplicator which 
measured the hydraulic performance of candidate valves, 
and an accelerated tester which tested the wear and 
Table 1. Evolution of valve models
Valve model Housing Disc Sewing ring Cause of failures
1. Titanium (welded housing) Delrin Polyester Weld failure. Water absorption by delrin
2. Titanium  (integral housing) Sapphire Polyester Wear of struts. Disc escape
3. #Haynes alloy + Titanium nitride coating Sapphire Polyester Fracture of disc.
4. Haynes alloy *UHMW-PE Polyester Successful.
#Haynes, cobalt based  superalloy.
*Ultra high molecular weight-polyethylene.
Figure 5. (a) TTK - Chitra valve in current use (model 4). (b) Fractured stunt (model 1). (c) Fractured disc (model 3).
(a)                          (b)         (c)
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durability of valves through 400 million cycles. When Laser 
Doppler Anemometry to measure the velocity fl ow profi le 
could not be set up due to budgetary constraints, his group 
developed an effective alternative – Pulsed Ultrasound 
Doppler Velocimetry. Innovation was not in short supply 
at any stage of the valve project (Bhuvaneshwar et al 1983, 
1991a, b, 1996, 1991).
After the clinical trial of the valvular prosthesis was 
approved by the IEC, the fi rst valve was implanted on 
6th December 1990 in a 38 year old teacher with aortic 
insuffi ciency who did well and is currently running a cyber 
cafe in Kerala. After 40 valves were implanted at the Chitra 
Institute with good results, IEC approved the multicentric 
trial of the valve in fi ve other major centres in India (Sankar 
Figure 6. Six cartoons indicating the changing perceptions on the development of Chitra valve.
(a)          (b)
(c)          (d)
(e)          (f)
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Kumar et al 2001). Ramani played a key role in producing 
350 clinical quality valves for the multicentric trials in the 
Techno-prove facility of the Chitra Institute in association 
with TTK, when the production process was standardized, 
QC/QA protocols developed and technology transfer done 
effectively by giving hands-on training to TTK personnel. 
Though Chitra Institute was the lead institution which 
conceptualized and developed the valvular prosthesis, 
its development would have been impossible without 
the support and expert assistance of several institutions 
including the National Aerospace Laboratory; Hindustan 
Aeronautics; Government Tool Room and Training Centre, 
Bangalore; South India Textile Research Association; 
National Chemical Laboratory; and the major hospitals 
listed in Bhuvaneshwar et al (1996). Far from the Indian 
stereotype of fatalism and indifference to suffering, the 
Chitra valve story brought home to us the core of goodness 
in Indians and their willingness to go the extra mile to help 
patients with serious illness. As our endeavour unfolded over 
a decade, it was greeted by a range of changing perceptions 
by the medical intelligentsia and media. They were captured 
at that time in a series of cartoons by Joy, who had a ring side 
view as the Institute’s medical artist (fi gure 6). 
The work of the multidisciplinary group at the Chitra 
Institute was not limited to the TTK-Chitra valve. During 
the same period, they developed and transferred for 
successful production a series of devices including a blood 
bag, disposable oxygenator, cardiotomy reservoir, polyester 
vascular graft, hydrocephalus shunt and dental composites. 
The family of Chitra devices formed the nucleus of a self-
regenerating base of medical technology conforming to 
international standards in India.
7. Soil in the heart
As the Technology Wing of the Chitra Institute quivered 
with excitement, its hospital counterpart was not far behind. 
In the nineteen sixties, a former classmate of mine, Professor 
C K Gopi, had observed in Thiruvananthapuram a heart 
disease among poor children, which resembled a malady 
reported from Uganda by Professor Davies a decade earlier. 
Severely malnourished and short of breath, the children had 
a puffy face, engorged veins in the neck, protuberant belly 
and emaciated legs. Treatment was ineffective and no more 
than 20% survived fi ve years after the onset of symptoms. 
The careful autopsy studies of Davies had shown the growth 
of a leathery, fi brous layer inside the pumping chambers of 
the heart, which progressed relentlessly and reduced the 
chamber size (fi gure 7). Furthermore, the fi brous growth 
stiffened the heart muscle which could no longer relax fully, 
and ultimately trapped and destroyed the valves between the 
atrial and ventricular chambers. Other organs were spared 
except secondarily as a consequence of heart failure. The 
cause of the disease – endomyocardial fi brosis (EMF) – was 
a mystery and speculations abounded.
As the outlook for medical treatment was poor and 
patients desperately ill, we adopted a surgical technique 
Figure 7. Interior of the left ventricle laid open at necropsy. Note the dense, white scar tissue (arrow) which progressively limits the 
chamber size of the ventricle and restricts the relaxation of the muscle.
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developed by a French surgeon – Dubost – for his patients 
with EMF from the Ivory Coast. The procedure consisted 
of cutting out the fi brous layer in the heart and replacing 
the diseased valves by an open heart operation. Though 
the operation carried a high mortality of 15%, 60% of the 
survivors were alive at the end of fi ve years, which was 
clearly preferable to the doom of medical treatment. In a 
decade we had the largest surgical series of EMF in the 
world including those reported from Ivory Coast and Brazil 
(Valiathan et al 1987).
In the nineteen eighties the reigning hypothesis on the 
causation of EMF was advanced by a British pathologist, 
Olsen, who claimed that the fi brous overgrowth in the 
heart in EMF was triggered by the breakdown products 
of eosinophils. Eosinophil count rises with all kinds of 
parasitic infections like fi lariasis in the tropics, and it seemed 
natural to Olsen that countries like Uganda would face the 
consequences of eosinophilia – the cardiac damage in EMF 
being possibly one of them. He was led to this hypothesis 
by his experience with a special kind of adult eosinophilia 
in Europe, which was associated with massive elevation of 
eosinophil count, rapid onset of a systemic illness and, in the 
terminal stage, morphological changes of the heart similar to 
those in EMF. This hypothesis of Olsen had been repeated 
in textbooks and journals so often that it had become a 
dogma among cardiologists. In a pathetic display of poor 
self-confi dence, pathologists from countries where EMF 
was prevalent were sending tissue samples to London for 
histopathologic interpretation! We were, however, in for a 
series of surprises as our studies got under way. In the fi rst 
place, patients with EMF had eosinophil counts which were 
no different from those of the common people in Kerala. 
Secondly, eosinophil proteins could not be detected by 
immunofl uorescence in the heart tissues removed during 
operation. Thirdly, we discovered that the highly endemic 
areas for fi lariasis in India such as Tanjore and Orissa where 
one would have expected a high incidence of EMF, were 
conspicuous by the absence of the disease. Throughout 
these exciting studies on EMF, I worked closely with Drs 
Kartha, Renuka, Shivakumar and Eapen, whose expertise in 
pathology, cell biology, biological chemistry and analytical 
chemistry were critical to the investigations.
8. Geochemical basis of EMF
As the fallacy of Olsen’s hypothesis became clear, we took 
a closer look at the global picture of EMF. We found that 
of nearly nine hundred authentic cases of EMF reported 
from all over the world, more than eight hundred and fi fty 
belonged to Nigeria, Uganda, Ivory coast, Tanzania, Kerala, 
Brazil and Venezuela. These far-fl ung spots on the map had 
one thing in common - they fell within 15% of the equator 
(fi gure 8). The only other common feature among them was 
poverty of varying degrees. Any hypothesis on the causation 
of EMF, we reasoned, had to take into account the twin 
realities of geography and poverty. 
What united the countries of the tropical belt were soil and 
climate: so at any rate we were told by the earth scientists. 
The well known examples of lung fi brosis caused by silica, 
asbestos and other substances also prompted us to look to 
the soil of Kerala for fi brogenic elements as a possible cause 
Figure 8. Global map: Pattern of distribution of reported cases of endomyocardial fi brosis (EMF) in 1982-85; the prevalence stood out in 
Ivory Coast, Nigeria, Uganda, Tanzania, Kerala, Brazil, and Venezuela.
A surgeon’s quest 323
J. Biosci. 33(3), September 2008
for the fi brosis in the heart. Rich in minerals, tropical soil 
contains a large variety of elements and their detection in 
tissue samples called for highly sophisticated methods of 
analysis. We were fortunate to receive excellent support in 
elemental estimation from the Centre for Earth Sciences, 
Thiruvananthapuram, Defence Metallurgical Research 
Laboratory, Hyderabad, Bhabha Atomic Research Centre 
(BARC), Mumbai and Indira Gandhi Atomic Research 
Centre, Kalpakkam.
Over the next few years, we analysed the cardiac 
tissue samples from patients for a variety of elements 
in the physiological, trace and toxic categories. Their 
concentrations were compared with those in cardiac tissues 
collected from ‘controls’ who consisted of subjects dying 
from accidents and undergoing medico-legal autopsy. A 
trend became visible in three years: the cardiac tissues from 
patients showed a lower concentration of magnesium and a 
higher level of thorium than the control samples (Valiathan 
et al 1986). In the initial estimations, BARC reported the 
concentrations for thorium and indicated the value for all 
other rare earth elements clubbed together as ‘RE’. As soon 
as we noted the higher concentration of thorium, we looked 
into the distribution of thorium in Kerala and found that 
monazite, one of the important minerals of Kerala, contains 
8% thorium whereas cerium accounts for nearly 30% by 
weight of the mineral. We therefore requested BARC to 
re-analyse the samples for cerium and sure enough, the levels 
of cerium were far higher than those of thorium (Valiathan et al 
1989). It appeared that thorium and cerium were the indicators 
of monazite in the heart. These were exciting fi ndings which 
suggested a role for soil elements in the causation of EMF. 
Indeed our report on the geo-chemical basis of EMF marked 
a point of departure and shifted the debate on the causative 
mechanism of the disease to the non-traditional context of 
geochemistry (Valiathan and Kartha 1990).
The geochemical basis, which we postulated as the basis 
for EMF, was straightforward. Magnesium is a physiological 
cation, which plays a crucial role in numerous biochemical 
reactions in the body. Children require more magnesium 
than adults because of the higher growth needs for the 
element. Poor children who subsist on rice and tuber crops 
like tapioca develop magnesium defi ciency, which may 
also be enhanced by the poor absorption of magnesium in 
the gut due to frequent episodes of diarrhea. While severe 
magnesium defi ciency is rare, mild and moderate defi ciencies 
are common among poor children in Kerala and other parts 
of the world. One of the biological effects of magnesium 
defi ciency is increased capillary permeability and greater 
transport of solutes in the gut. It is also well documented 
that soil and water in Kerala are low in magnesium.
In the coastal regions of Kerala, small children playing 
on the sand with bare feet and hands is a common sight. 
Monazite grains which are minute, stick to the hand easily 
and get ingested in small quantities in children. This had 
been noted earlier during a survey of the Kerala coast by 
BARC scientists. They had also observed that tuber crops 
such as tapioca and elephant yam concentrate rare earth 
elements. When the children with magnesium defi ciency 
ingest toxic elements directly through sand or indirectly 
through tuber crops, the elements are prone to get absorbed 
thanks to the increased permeability of the gut mucosa. 
The geochemical hypothesis had the merit that it 
addressed the central issues in the clinico-epidemiological 
profi le of EMF. The equatorial prevalence of the disease 
could be traced to the presence of monazite in the tropical 
soil, whose footprints of cerium were detectable in the 
heart tissues. The poverty of patients, on the other hand, 
found expression in magnesium defi ciency which, so to 
say, softened the natural barriers of the mucosa to enable 
the entry of cerium. But the hypothesis raised a host of 
questions: some physico-chemical, others biomedical. 
9. Geochemical basis – experimental support
As the initial excitement subsided, we were confronted by 
the question whether the lower concentration of magnesium 
and higher level of cerium were functionally coupled at 
all? Perhaps they were independent of each other, and we 
were conjuring a connection that did not exist? To settle this 
question, an experiment was carried out in a tuber crop – 
Coleus parvifl orus – in culture. The plant model was chosen 
because tuber crops are consumed by patients and are 
reported to concentrate rare earth elements. When cerium 
was added to the medium which contained magnesium, the 
plant did take up cerium; but the uptake was twice as high 
when the magnesium content in the medium was halved. 
This confi rmed that reverse changes in the levels of Mg and 
Ce were connected and reciprocal (Nair et al 1989). Then 
arose the question whether a lanthanide like cerium could 
play the role of magnesium in enzymatic reactions which 
form the core of life processes. An interesting study soon 
answered the query. Cibacron blue F3G-A is a substrate 
analogue of creatine kinase which is an important enzyme in 
muscle physiology. The enzyme cannot bind to its substrate 
without magnesium, which is an essential cofactor. An 
experiment showed that the binding would take place just 
as effi ciently with cerium or thorium as with magnesium 
(Shivakumar et al 1989). Other crucial experiments showed 
that cerium acted at the transcription level in nanomolar 
concentration and stimulated fi broblasts in culture to 
produce collagen (Shivakumar et al 1992; Preeta and Nair 
1999). These and other studies suggested that cerium could 
mimic magnesium and be biologically active under given 
conditions. The possibility of cerium occupying the slot of 
magnesium does not of course imply that the end result of the 
enzymatic reaction would be identical. Unlike magnesium, 
which forms reversible bonds and maintains the dynamic 
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conditions of the cell, cerium is likely to form irreversible 
bonds with biological ligands and cause the death of the cell. 
When the regular player is missing and his place is taken by 
an impostor with no music in his soul, the orchestra would 
produce cacophony instead of harmony.
The proof for the geochemical basis lay in the production 
of EMF in an animal model, which we knew would be 
far from easy. In our experiments, rats which were fed a 
magnesium defi cient diet and given cerium adulterated 
water, showed magnesium defi ciency, enhanced level of 
cerium, increased collagen content and fi brotic changes 
in the heart which are characteristic of EMF (Kumar et al 
1996). In repeating the study in rabbits, we also observed 
changes in the pressure curve in the left ventricle, which 
are a hallmark of diastolic dysfunction or failure to relax in 
EMF (Kartha et al 1998). This was as close as one could get 
to the fi nal proof in the causation of the disease. It cheered 
us that the geochemical basis of EMF found mention in 
most standard international texts of cardiology and reviews 
on cardiomyopathies. 
Two decades after the publication of our initial reports on 
EMF, the prevalence of the disease has declined in Kerala. 
At the Chitra Institute which attracted the majority of these 
very sick patients, their percentage among all cardiac cases 
registered from 1983 – 1985 averaged 0.6% per year, which 
dropped to 0.2% in 2003 – 2005 even though the admission 
policy of the institution had not changed. Professor Sezi of 
Makarere University, Uganda where EMF was discovered by 
Professor Davies told me even in 1997 that they saw fewer 
patients with EMF, which he attributed to the better nutrition 
of poor children following the introduction of a “fi sh meal” 
scheme for children by the Ugandan Government. Better 
nutrition of children would correct magnesium defi ciency 
and could account for the decreasing prevalence of EMF in 
Kerala as well. Our studies on EMF could claim no credit for 
this happy turn of events but they would suggest a possible 
mechanism for the prophylactic role of good nutrition in the 
decline of EMF.
10. In Caraka’s company
To everything there is a season and a time to every purpose, 
said the Preacher. I laboured in the Chitra vineyard for two 
decades when the pickings were not bad. My long season 
ended in 1994 when I opted for a break with the past of 
several decades in cardiac surgery. The break was not only 
geographic and professional but also intellectual. Some 
years earlier, I had read the Caraka Samhita while preparing 
to give the Gandhi lecture at the Raman Research Institute, 
Bangalore, and felt that there was more in it “than met the 
eye”. After the lecture, Professor Satish Dhawan put his arm 
around my shoulder and said to me “Valiathan, I had heard 
Caraka’s name but never knew that such ideas had been 
conceived in India so long ago. You should write on the 
subject seriously”. The time for seeking Caraka’s company 
came fi ve years after my departure from the Chitra Institute, 
and my steps have revolved ever since among the gurukulas 
of Caraka, Susruta and Vagbhata (three ancient authorities 
of Ayurveda). My two studies on them were published, and a 
third is on the way (Valiathan 2003, 2007). In this journey to 
the past, I no longer fret over traffi c jams because there are 
none; nor do I worry about overtaking or being overtaken! 
As I switch to the slow lane, I am not unaware that “the past 
is preserved by itself, automatically. In its entirety, probably, 
it follows us at every instant. We think only with a small 
part of our past, but it is with our entire past, including 
the original bent of our soul, that we desire, will and act” 
(Bergson 2005).
P C Ray regarded the centuries from 600 BC – 800 AD 
as the Ayurvedic period in India because Ayurveda (literally, 
knowledge of life) was not only the mother of life sciences 
but also the cradle of chemistry. After nine centuries of 
neglect and two of active suppression, Ayurveda had an 
unprecedented resurgence in India during the twentieth 
century. According to some estimates 70% of Indians use 
Ayurvedic treatment regularly or periodically. The number 
of Ayurvedic physicians graduating every year exceeds 
12000 and their role in health care delivery is expanding 
rapidly. The herbal drug industry is booming. In spite of 
these developments, scientifi c studies in Ayurveda have been 
minimal thanks to the rigid segregation of the scientifi c and 
Ayurvedic communities in India. There has been virtually 
no scientifi c interest in Ayurveda except in herbal drugs. 
This has impoverished science and Ayurveda and deprived 
science of the opportunity to explore an uncharted land of 
great promise at home. Several years of textual study have 
persuaded me that concepts, procedures and products exist in 
Ayurveda, which would lend themselves to investigation by 
the methods of modern science. These studies would include, 
for example, the possible genomic basis of dosha prakritis 
(three primary dosha prakritis consist of three groups of 
physical, behavioural and psychological traits. Fixed at 
the time of conception and unalterable, they determine 
the manifestation of disease and response to treatment in 
individuals); functional genomic studies of three groups 
of anti-dosha plants (groups of plants believed to counter 
the disorders caused by the imbalance of three doshas); 
metabolic and immunologic correlates of panchakarma (fi ve 
evacuative procedures following elaborate preparation to 
clear the body of “toxins”; highly popular, they are claimed 
to have effi cacy in several degenerative diseases), the 
effect of rasayanas on DNA chain break repair (procedures 
and drugs to promote ageing without infi rmities); and 
the microstructure of bhasmas (powders prepared from 
metals and minerals after elaborate processing: potent and 
claimed to be non-toxic). It has gratifi ed me that established 
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scientists from reputed institutions and universities all 
across India and senior Ayurvedic physicians are taking 
part in these collaborative studies which form the core of “A 
Science Initiative in Ayurveda”. These are projects in basic 
science, each taking a cue from traditional knowledge and 
each contributing strands of varied hues for the fabric of 
Ayurvedic Biology (Valiathan 2006).
11. Epilogue
Now the twilight has come, when the day merges into the 
night. I am fortunately in good health and able to travel and 
work hard everyday. Like Marcus Aurelius, I could fi ll an 
entire page expressing my gratitude to a great variety of 
individuals in three continents. I have many blessings to 
count, and no regrets or disappointments. Sometimes a tinge 
of regret does appear like a fl eeting shadow that I forfeited 
the chance to learn Veena from my mother and gain better 
profi ciency in Sanskrit from my teacher Rama Sastri in my 
school days. Recently, we had a reunion of the 1951 batch 
of the Trivandrum Medical College. The Grim Reaper had 
claimed a third of our group and some were ill. Those who 
came were reputed and senior physicians who had occupied 
high positions and enjoyed professional success in Kerala. 
As I sat among them, it struck me that my life and work had 
been cast so very differently from theirs. I left Trivandrum 
after graduation and spent fi ve years in the UK and US 
for postgraduate training; thereafter, my serial stops of 
varying duration included Mumbai, Chandigarh, Baltimore, 
Washington DC, Delhi, Chennai, Trivandrum and Manipal. 
I was blown hither and thither by great winds which I could 
neither comprehend nor control. My nomadism was not 
limited to geography; it cast a spell on my mind as well. 
From cardiac surgery and research on EMF, I moved so 
deeply into biomedical engineering that I was made a Fellow 
by the National Academy of Engineering; the next phase 
saw me in the fi eld of higher education as a Vice-Chancellor, 
when I had nothing to do with what I had done earlier; now, 
as I walk into sunset, I have gone back in time to live in the 
company of Caraka, Susruta and Vagbhata and develop a 
science initiative in Ayurveda for the 21th century. Far from 
grudging, I must admit that nomadism agrees with me and 
invigorates me with fresh doses of energy.
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